Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Jul 7;21(25):7911-5.
doi: 10.3748/wjg.v21.i25.7911.

Helicobacter cinaedi bacteremia with cellulitis after ABO-incompatible living-donor liver transplantation: Case report

Kohei Mishima  1 , Hideaki Obara  1 , Kayoko Sugita  1 , Masahiro Shinoda  1 , Minoru Kitago  1 , Yuta Abe  1 , Taizo Hibi  1 , Hiroshi Yagi  1 , Kentaro Matsubara  1 , Takehiko Mori  1 , Yaoko Takano  1 , Hiroshi Fujiwara  1 , Osamu Itano  1 , Naoki Hasegawa  1 , Satoshi Iwata  1 , Yuko Kitagawa  1
Affiliations
Case Reports

Helicobacter cinaedi bacteremia with cellulitis after ABO-incompatible living-donor liver transplantation: Case report

Kohei Mishima et al. World J Gastroenterol. .

Abstract

Helicobacter cinaedi (H. cinaedi), a Gram-negative spiral-shaped bacterium, is an enterohepatic non-Helicobacter pylori Helicobacter species. We report the first case of H. cinaedi bacteremia with cellulitis after liver transplantation. A 48-year-old male, who had been a dog breeder for 15 years, underwent ABO-incompatible living-donor liver transplantation for hepatitis C virus-induced decompensated cirrhosis using an anti-hepatitis B core antibody-positive graft. The patient was preoperatively administered rituximab and underwent plasma exchange twice to overcome blood type incompatibility. After discharge, he had been doing well with immunosuppression therapy comprising cyclosporine, mycophenolate mofetil, and steroid according to the ABO-incompatible protocol of our institution. However, 7 mo after transplantation, he was admitted to our hospital with a diagnosis of recurrent cellulitis on the left lower extremity, and H. cinaedi was detected by both blood culture and polymerase chain reaction analysis. Antibiotics improved his symptoms, and he was discharged at day 30 after admission. Clinicians should be more aware of H. cinaedi in immunocompromised patients, such as ABO-incompatible transplant recipients.

Keywords: ABO-incompatible; Bacteremia; Cellulitis; HBc-Ab-positive donor; Helicobacter cinaedi; Hepatitis C; Liver transplantation; Living-donor.

PubMed Disclaimer

References

    1. Flahou B, Haesebrouck F, Smet A, Yonezawa H, Osaki T, Kamiya S. Gastric and enterohepatic non-Helicobacter pylori Helicobacters. Helicobacter. 2013;18 Suppl 1:66–72. - PubMed
    1. Solnick JV, Schauer DB. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev. 2001;14:59–97. - PMC - PubMed
    1. Nadig SN, Bratton CF, Karp SJ. Marginal donors in liver transplantation: expanding the donor pool. J Surg Educ. 2007;64:46–50. - PubMed
    1. Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol. 2010;52:272–279. - PubMed
    1. Tanabe M, Shimazu M, Wakabayashi G, Hoshino K, Kawachi S, Kadomura T, Seki H, Morikawa Y, Kitajima M. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation. 2002;73:1959–1961. - PubMed

Publication types

MeSH terms